Although seldom fatal, persistent infection by chikungunya virus (CHIKV) afflicts patients with joint pain lasting months or even years. This insect-borne virus has received relatively little scientific attention in the 50 ...
Jul 3, 2013
0
0
National Institutes of Health (NIH) scientists studying an emerging coronavirus have found that a combination of two licensed antiviral drugs, ribavirin and interferon-alpha 2b, can stop the virus from replicating in laboratory-grown ...
Apr 18, 2013
0
0
A breakthrough in cancer treatment just nine years ago has brought new hope to millions of people whose cancers are resistant to all other therapies. The new treatment, cancer immunotherapy, frees the body's potent immune ...
Sep 15, 2021
0
17
A simple blood test can be used to predict which chronic hepatitis C patients will respond to interferon-based therapy, according to a report in the May issue of Cellular and Molecular Gastroenterology and Hepatology, the ...
May 13, 2015
0
5
(HealthDay)—The American Academy of Neurology's (AAN's) Top Five Recommendations in the Choosing Wisely campaign, established to promote high-value neurologic medicine and to foster physician-patient communication, have ...
Feb 25, 2013
0
0
The immune system has a delicate balance to maintain. When certain infected cells detect an invader, they use a molecule called interferon to rally the body's defenses. The immune system responds to this rallying cry by immediately ...
Feb 2, 2015
0
9
Results from a Michigan Medicine study reveal that targeting a protein found in the skin may reduce the severity of psoriasis.
Aug 12, 2021
0
164
The recent Ebola outbreak in West Africa has claimed more than 11,300 lives and starkly revealed the lack of effective options for treating or preventing the disease. Progress has been made on developing vaccines, but there ...
Nov 18, 2015
0
23
Since its approval in 2011, the multiple sclerosis drug fingolimod (Gilenya) has already undergone three early benefit assessments, all of which were mainly based on the approval study TRANSFORMS. After a new modification ...
Mar 8, 2016
0
9
In a study reported in Nature this month, Yerkes National Primate Research Center researchers were key in determining that treating SIV-infected rhesus macaques with type 1 interferon, a protein known to trigger antiviral ...
Jul 23, 2014
0
0
